APA (7th ed.) Citation
(2026). Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer. Breast Cancer : Targets and Therapy.
Chicago Style (17th ed.) Citation
"Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer." Breast Cancer : Targets and Therapy 2026.
MLA (9th ed.) Citation
"Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer." Breast Cancer : Targets and Therapy, 2026.
Warning: These citations may not always be 100% accurate.